Evidence-based management of dyslipidaemia: Hong Kong family physicians' perspective

Hong Kong Practitioner

Volumn 23, Issue 5, 2001, Pages 191-200

  Wun, Y T ^a   Tang, J L ^a   Chao, D V K ^a  

^a Lek Yuen Health Centre   (Hong Kong)

Author keywords

Cholesterol; Family physicians; Guidelines; Lipid; Management

Indexed keywords

ANTILIPEMIC AGENT;

AGE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; GENDER; GENERAL PRACTICE; GENERAL PRACTITIONER; GOVERNMENT; HONG KONG; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; PATIENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY PREVENTION; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SKILL;

EID: 0035001245     PISSN: 10273948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cholesterol lowering and mortality: The importance of considering initial level of risk
2. Choice and use of blood lipid tests. An epidemiologic perspective
3. Cholesterol and cardiovascular disease. An overview of Lipid Research Clinics (LRC) epidemiological studies as background for the LRC Coronary Primary Prevention Trial
4. High density lipoprotein and coronary heart disease
5. Lipoproteins and coronary heart disease in the Helsinki Heart Study
6. Primary prevention of coronary heart disease: Integrating risk assessment with intervention
7. Adjusting therapy to cardiovascular risk status
8. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
9. Prevention of coronary heart disease in clinical practice: Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
10. 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia
11. Joint British recommendations on prevention of coronary heart disease in clinical practice
12. Doctors are ethically obliged to advise patients to quit smoking
13. Updated New Zealand cardiovascular disease risk-benefit prediction guide
14. Coronary and cardiovascular risk estimation for primary prevention: Validation of a new Sheffield table in the 1995 Scottish health survey population. (CORRECTIONS: BMJ 2000; 320:1034)
15. Coronary heart disease and dyslipidaemia in Hong Kong: A survey of the knowledge and opinions of medical practitioners